Definitive Healthcare Corp (DH) looking to reclaim success with recent performance

With 0.71 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.64 million shares. The 52-week range on DH shows that it touched its highest point at $10.62 and its lowest point at $3.19 during that stretch. It currently has a 1-year price target of $5.25. Beta for the stock currently stands at 1.44.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DH was down-trending over the past week, with a drop of -11.35%, but this was up by 1.03% over a month. Three-month performance surged to 17.70% while six-month performance rose 13.36%. The stock lost -46.64% in the past year, while it has gained 19.71% so far this year. A look at the trailing 12-month EPS for DH yields -3.11 with Next year EPS estimates of 0.29. For the next quarter, that number is 0.07. This implies an EPS growth rate of 14.56% for this year and -14.35% for next year. EPS is expected to grow by 2.83% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -64.67%.

Float and Shares Shorts:

At present, 115.44 million DH shares are outstanding with a float of 45.13 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for DH since 10 analysts follow the stock currently. There are 5 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 4 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.3538 being high and $0.33726 being low. For DH, this leads to a yearly average estimate of $0.34369. Based on analyst estimates, the high estimate for the next quarter is $0.09 and the low estimate is $0.06. The average estimate for the next quarter is thus $0.07.